The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
First-, second-, third-line therapy for metastatic renal cell carcinoma (mRCC): Benchmarks for trials design from the International mRCC Database Consortium (IMDC).
Daniel Yick Chin Heng
Consultant or Advisory Role - Bayer; Novartis; Pfizer
Brian I. Rini
Consultant or Advisory Role - AVEO; Bayer/Onyx; GlaxoSmithKline; Pfizer
Research Funding - GlaxoSmithKline; Pfizer
Jae-Lyun Lee
Honoraria - Bayer; Novartis; Pfizer
Research Funding - Bayer
Nils Kroeger
No relevant relationships to disclose
Sandy Srinivas
No relevant relationships to disclose
Lauren Christine Harshman
Consultant or Advisory Role - Novartis; Pfizer
Research Funding - Bristol-Myers Squibb; Genentech; Novartis
Jennifer J. Knox
Consultant or Advisory Role - AVEO
Research Funding - Pfizer
Georg A. Bjarnason
Consultant or Advisory Role - Pfizer
Research Funding - Pfizer
Mary J. MacKenzie
Honoraria - Novartis; Pfizer
Lori Wood
Consultant or Advisory Role - GlaxoSmithKline (U); Novartis (U); Pfizer (U)
Research Funding - GlaxoSmithKline; Novartis; Pfizer
Ulka N. Vaishampayan
Consultant or Advisory Role - Dendreon; Janssen Oncology; Novartis; Pfizer
Research Funding - Genentech/Roche; Novartis
Other Remuneration - Dendreon (Speakers Bureau); Genentech/Roche; Janssen Biotech (Speakers Bureau); Medivation (Speakers Bureau); Novartis (Speakers Bureau); Pfizer (Educational Presentation Development); Pfizer (Speakers Bureau)
Neeraj Agarwal
No relevant relationships to disclose
Sumanta Kumar Pal
No relevant relationships to disclose
Min-Han Tan
No relevant relationships to disclose
Sun Young Rha
Consultant or Advisory Role - GlaxoSmithKline; Novartis; Pfizer
Research Funding - Bayer; Novartis
Takeshi Yuasa
No relevant relationships to disclose
Frede Donskov
Research Funding - Novartis
Aristotelis Bamias
Consultant or Advisory Role - Novartis; Pfizer; Roche
Scott A. North
No relevant relationships to disclose
Toni K. Choueiri
Consultant or Advisory Role - AVEO; Bayer/Onyx; Genentech; GlaxoSmithKline; Novartis; Pfizer
Research Funding - Pfizer